Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate safety and efficacy of intranasal insulin in abstinent smokers.
Groups' (placebo vs. insulin) cognitive function and stress response will be compared.